EVEREST II High Surgical Risk Cohort: Clinical Benefit by MR Grade in High Surgical Risk Patients One Year Following MitraClip Therapy.

Presenter: Paul Grayburn, Saibal Kar, Ted Feldman, Donald Glower, Elyse Foster, Laura Mauri

REGISTER for free or LOG IN to view this content

EVEREST II High Surgical Risk Cohort:  Clinical Benefit by MR Grade in High Surgical Risk Patients One Year Following MitraClip Therapy.

We Recommend